Biotricity, Inc. BTCY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -959.50K | -324.20K | -717.10K | -690.90K | -672.00K |
| Total Depreciation and Amortization | 127.80K | 123.70K | 119.70K | 226.90K | 112.40K |
| Total Amortization of Deferred Charges | 196.60K | 204.70K | 185.50K | 202.10K | 153.60K |
| Total Other Non-Cash Items | 450.00K | 6.70K | 189.40K | -96.10K | 22.70K |
| Change in Net Operating Assets | 692.20K | -31.90K | -517.80K | 773.60K | 10.00K |
| Cash from Operations | 507.20K | -20.90K | -740.30K | 415.60K | -373.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -162.50K | 804.30K | 298.40K | 441.60K |
| Total Debt Repaid | -184.90K | 77.00K | -77.00K | -600.00K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 0.00 | 0.00 | -200.00K | -- |
| Total Dividends Paid | -6.00K | -6.00K | -6.00K | -6.10K | -5.90K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -190.90K | -91.50K | 721.30K | -507.70K | 435.70K |
| Foreign Exchange rate Adjustments | 400.00 | 5.90K | -33.10K | 9.30K | -36.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 316.70K | -106.60K | -52.10K | -82.80K | 26.10K |